The cadherin switch assessment in the epithelial-mesenchymal transition of urothelial bladder carcinomas.
By: Andrei Ioan Drocaş, Paul Ioan Tomescu, George Mitroi, Petru Octavian Drăgoescu, Claudiu Mărgăritescu, Alex Emilian Stepan, Valeriu Şurlin, Ştefania CrăiŢoiu, Ileana Drocaş, Anca Marilena Ungureanu, Alice Elena Găman, Adriana Turculeanu, Cristiana Eugenia Simionescu

Department of Pathology, University of Medicine and Pharmacy of Craiova, Romania; astepan76@yahoo.com.
2016-12-22; doi:
Abstract

Introduction

The epithelial-mesenchymal transition (EMT) process is a complex molecular mechanism that is involved in the acquisition of an aggressive, invasive and metastatic phenotype by carcinomas. The cadherin switch consists in the alteration of E-cadherin and N-cadherin expression and is specific for the EMT process.

Materials

This study included 35 cases of primitive urothelial carcinomas investigated in relation with clinicopathological prognostic parameters and expression of E- and N-cadherins in the advancing edge and intratumoral compartments.

Results

In both compartments, the immunoexpression of E-cadherin decreased, while that of N-cadherin increased in high grade, deeply invasive, or those cases with lymph node metastases and advanced stages carcinomas, with a negative linear correlation observed between their expression percentage values. In this study, it was observed the presence of cadherin switch in urothelial carcinomas, the variation of the two proteins' immunostaining patterns being higher at the advancing edge. The presence of N-cadherin in intratumoral compartment designated it as actively involved in EMT process.

Conclusions

The analysis of cadherins switch can be used to identify superficial urothelial carcinoma with invasion and metastasis potential.





PMID:28002521






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements